TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media
Download Report PDF Instantly
Report overview
This report contains market size and forecasts of Dermatological OTC Drugs in Global, including the following market information:
The global Dermatological OTC Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Acne Medications Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Dermatological OTC Drugs include Perrigo Company plc, Bausch Health Companies Inc., Dr. Reddy's Laboratories, Johnson and Johnson, Bayer AG, GlaxoSmithKline plc., Viatris Inc, LEO Pharma A/S and Acella Pharmaceuticals, LLC, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Dermatological OTC Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Dermatological OTC Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Dermatological OTC Drugs Market Segment Percentages, by Type, 2021 (%)
Global Dermatological OTC Drugs Market, by Distribution Channel, 2017-2022, 2023-2028 ($ millions)
Global Dermatological OTC Drugs Market Segment Percentages, by Distribution Channel, 2021 (%)
Global Dermatological OTC Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Dermatological OTC Drugs Market Segment Percentages, By Region and Country, 2021 (%)
Competitor Analysis
The report also provides analysis of leading market participants including:
Further, the report presents profiles of competitors in the market, key players include:
